Atlas Trials

Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer

Clinical trial NCT00038402 · COMPLETED

Trial details

NCT number
NCT00038402
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2001-04-01
Primary completion
2004-11-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.